Clinical Study
The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
| Clinical Factors | Adjusted Hazard Ratio | 95% CI | P |
| Age (years old) | 0.96 | 0.92-1.00 | 0.070 | BMI (≥23kg/m2) | 0.78 | 0.37-1.61 | 0.494 | Gender (male) | 0.58 | 0.26-1.30 | 0.187 | Previous PCI | 2.41 | 1.03-5.65 | 0.043 | Diabetes mellitus | 2.58 | 1.29-5.15 | 0.007 | Hypertension | 0.70 | 0.31-1.60 | 0.397 | CRF | 2.37 | 0.94-5.98 | 0.068 | Dyslipidemia | 0.56 | 0.27-1.14 | 0.108 | Current smoking | 0.92 | 0.37-2.30 | 0.858 | FHx of CAD | 0.98 | 0.35-2.71 | 0.967 | LV dysfunction (<40%) | 2.01 | 0.41-9.76 | 0.387 | Multivessel disease | 1.20 | 0.52-2.81 | 0.669 | Hemoglobin (g/dl) | 0.94 | 0.77-1.16 | 0.586 | CRP (mg/dl) | 1.03 | 0.73-1.44 | 0.889 | Type B2/C lesion | 1.46 | 0.64-3.37 | 0.371 | Reference vessel diameter (mm) | 0.77 | 0.44-1.35 | 0.366 | Lesion length (mm) | 0.99 | 0.97-1.01 | 0.208 | Pre-procedure DS (%) | 1.01 | 0.98-1.04 | 0.546 | Post-procedure DS%, in- stent (mm) | 1.08 | 1.05-1.11 | <0.001 |
|
|
TLR, target lesion revascularization; CI, confidence interval; BMI, body mass index; PCI, percutaneous coronary intervention; CRF, chronic renal failure; FHx, family history; CAD, coronary artery disease; LV, left ventricle; CRP, C-reactive protein; DS, diameter stenosis.
|